Rheumatoid Arthritis Case Study Questions & Answers

Slide 5:

  • What is significant about this report that leads you to RA?

Pain in hands bilaterally, stiffness, tenderness in the morning, poor appetite and easily fatigued

RA affects women > men and is most common 40-60 yrs old

  • What additional nursing assessment data would be significant?

Joints spongy feeling, warm/hot, swollen, not easily moved, fever, weight loss, Raynaud’s phenomenon (cold & stress induced vasospasms that cause white/cyanotic coloring

Slide 7:

  • Patient has mild OA and is now being diagnosed with RA, explain the differences to her.

RA is typically symmetrical OA is not

RA targets smaller joints first and OA tends to affect larger joints first

RA is synovitis of the joints (inflammation of the synovial lining), OA is “wear & tear” breakdown of cartilage

OA is more common

RA is more debilitating & crippling

RA is autoimmune, systemic

RA is remissions & exacerbations

Morning stiffness is < 30 mins in OA and > 1 hour in RA

Slide 10:

  • How will these laboratory values be affected or how will they assist in the diagnosis of RA?

RBC & HcT are decreased – chronic inflammation

CRP – elevated indicates active inflammation (Normal is less than 1 mg/dL)

ESR – elevated indicates inflammatory process (Normal is 0-15 Men, 0-25 Women)

RF – Positive in 80% of RA patients , not a specific indicator of RA

ACPA – Positive can indicate RA, not a specific indicator of RA

Synovial Fluid – cloudy with increased leukocytes present

Xray – narrowed joint spaces, not typically seen in the first 3-6 months, also done to determine progression

Slide 12:

  • According to the American College of Rheumatology what are the 4 sets of data to classify RA?

Joint involvement - number & small or large joint

Serology - RF & ACPA

Acute phase reactants - CRP & ESR

Duration of symptoms - less than or greater than 6 weeks

  • Explain what these 2 classes of medications are & how they work?

NSAID (NonsteroidalAntiinflammatory Drug) – reduce inflammation to decrease pain, swelling, improve function. Do not affect the disease process. GI side effects – dyspepsia, ulcers, cardiovascular risks. See results quicker

DMARD (Disease Modifying Antirheumatic Drug) – have potential to decrease joint damage, slow progression of disease, preserve joint function, should be started with 3 months of diagnosis. Cause immunosuppression. Slower onset on action.

  • Why is PT/OT involved so early on when there isn’t a current mobility problem?

To help preserve joint function; teach the patient ways to decrease stress on joints; ROM; muscle strengthening; teach appropriate exercises

  • What additional teaching should be completed at this time??

This is a chronic progressive disease that can affect other organs and it can impact all areas of life; how to deal with pain, fatigue, and depression that can occur; importance of treatment compliance and follow-up; this disease cannot be cured – but treatment can be very effective;

What are examples of NSAIDS & DMARDS that could be used at this time?

NSAIDS – naproxen (Naprosyn), ibuprofen (Motrin), celecoxib (Celebrex), meloxicam (Mobic), Diclofenac (Voltaren)

DMARDS – hydoxychloroquine (Plaquenil), leflunomide (Arava), methotrexate (Rheumatrex), sulfasalazine (Azulfidine), abatacept (Orencia), rituximab (Rituxan), etanercept (Enbrel), infliximab (Remicade), adalimumab (Humira)

Slide 14:

  • Prior to starting this treatment plan what should be evaluated?

Cardiovascular risk factors, liver enzymes, CBC, creatinine, pregnancy status, history of GI bleeding, presence of infection

  • What patient teaching is indicated for these medications? Have student’s role play patient teaching

Labs – Liver enzymes, Immunizations should be administered prior to DMARD therapy, watch for signs of GI bleeding, watch for signs of infection, compliance with follow-up labs is essential,

Methotrexate needs to be taken exactly as presecribed (weekly in this case), take on empty stomach

Celebrex – take with food

  • When would these medications be contraindicated?

Pregnancy, significant cardiac risk factors or hepatic or renal impairment

Slide 15:

  • Appropriate nursing diagnoses include:

Acute or chronic pain

Fatigue

Imbalanced nutrition: less than body requirements

Sleep deprivation

Activity intolerance

Impaired physical mobility

Self-care deficit

Disturbed body image

Ineffective coping

Fear

Anxiety

Powerlessness

Risk for infection related to treatment methods

Knowledge deficit: disease process or treatment

Slide 18:

  • What new patient teaching should be included?

Humira:

Avoid live vaccines while taking it

Prior to giving it TB screening should be completed

Serious infections can occur

Teach self administration – it is a subcutaneous injection (abdomen, rotate sites, needle care/disposal)

It should be kept refrigerated

Slide 20:

  • What information should be taught to Mrs. About the use/administration of Remicade?

It is given via IV infusion over at least a 2 hour period, then repeat in 2 weeks, then at 6 weeks, then every 8 weeks

If she is going to continue to get Remicade regularly a central line (port-a-cath) could be beneficial for her

Monitor for infusion related reaction during and for 2 hours after infusion (reactions are more common after 1st or 2nd infusion)

Monitor for symptoms of systemic infections/fungal infections

TB skin test prior to beginning therapy

Monitor for reactions

Monitor liver function

Monitor CBC (leukopenia, neutropenia, thrombocytopenia, pancytopenia)

Slide 22:

  • What should the nurse monitor for during the initial infusion in regards to a reaction?

Fever

Chills

Itching

Rash

Dyspnea

Hypotension/Hypertension

Chest pain

Both during and for 2 hours following the infusion

  • If she were to have a reaction what should the nurse do?

Stop the infusion

Call the MD

Prepare to administer antihistamines, corticosteroids, acetaminophen, and/or epinephrine

Slide 24:

  • What are some common signs of disease progression? And extra articular signs of RA?

To view photos of these deformities please visit

Swan neck deformities

Rheumatoid nodules

Boutonniere’s deformity

Ulnar deformity

Hallux toes

Raynaud’s phenomenon – cold or stress induced vasospasm causing white/blue coloring of fingers

Sjogren’s syndrome – dry eyes & mucous membranes

Increased risk for cardiac disease (vasculitis, pericarditis)